About this trial
The purpose of this study is to compare to assess the incidence of post-operative complications related to nephrectomy, which occur up to 1 month after the operation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients over 18 ;
Localised kidney cancer ;
Validation of curative treatment at a multidisciplinary consultation meeting;
Partial or total laparoscopic nephrectomy scheduled on an outpatient basis;
Disqualifiers
Emergency intervention ;
Patient not eligible for outpatient treatment;
Long-term curative anti-coagulant treatment ;
Resident more than 100km from the clinic;
Trial population
Adult patients diagnosed with localised kidney cancer, undergoing scheduled surgery for partial or total laparoscopic nephrectomy on an outpatient basis.
Trial design
Cohort
Prospective
Treatments tested in this trial
Partial or total laparoscopic nephrectomy
Procedure/SurgeryNephrectomy is currently the primary indication for localised kidney cancer. All patients consulting a surgeon at the Clinique de la Sauvegarde for localised kidney cancer, for which surgical excision has been validated by the multidisciplinary consultation meeting and who are eligible for outpatient treatment, will be offered the opportunity to take part in this study during the preoperative consultation.
Treatment groups
Trial outcomes
Primary outcomes
Incidence of complications
The study will observe the incidence and describe the type, number, severity, duration and frequency of complications that may arise in the immediate post-operative period following ambulatory nephrectomy.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead sponsor
Euraxi Pharma
Collaborator